EGB Ventures is a family office dedicated to forming, financing and developing innovative companies that advance clinical-stage pharmaceutical products addressing critical, unmet medical needs. Our goal is to transform promising science into therapies that make a meaningful difference in patient care, while generating value for investors.
We actively form new ventures, recruit exceptional executives, and collaborate closely with strategic investment partners and global networks of physicians, scientists, and entrepreneurs. By combining deep clinical insight with financial expertise, we accelerate the journey from concept to clinic while maintaining rigorous governance and strategic discipline.
Our proven track record includes building companies with more than $1B of combined market value, demonstrating our unique ability to de-risk investments by uncovering existing drugs and repurposing them to unlock their full potential.
EGB Ventures builds companies with the structure and governance to support future access to public markets, when the timing and maturity of the business align. This approach enhances transparency and capital access, supporting long-term value creation and improved patient outcomes.